Dr Mark Ndugo Keigi, MD in Bear, DE - General Practice

Dr Mark Ndugo Keigi, MD is a General Practice physician based in Bear, Delaware. Dr Mark Ndugo Keigi is licensed to practice in Missouri (license number 2019034785) and his current practice location is 2821 Squirrel Dr, Bear, Delaware. He can be reached at his office (for appointments etc.) via phone at (786) 328-9209.

NPI number for Dr Mark Ndugo Keigi is 1043841620 and his current mailing address is 2821 Squirrel Dr, Bear, Delaware. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043841620.

Contact Information

	Dr Mark Ndugo Keigi, MD
	2821 Squirrel Dr, Bear, DE 19701-2765
	(786) 328-9209
	Not Available

Physician's Profile

Full Name	Dr Mark Ndugo Keigi
Gender	Male
Speciality	General Practice
Location	2821 Squirrel Dr, Bear, Delaware
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1043841620
Provider Enumeration Date: 01/31/2020
Last Update Date: 01/31/2020

Medical Identifiers

Medical identifiers for Dr Mark Ndugo Keigi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043841620	NPI	-	NPPES
2019304785	Other	MO	ASSISTANT PHYSICIAN LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	2019034785 (Missouri)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark Ndugo Keigi is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark Ndugo Keigi, MD 2821 Squirrel Dr, Bear, DE 19701-2765 Ph: (786) 328-9209	Dr Mark Ndugo Keigi, MD 2821 Squirrel Dr, Bear, DE 19701-2765 Ph: (786) 328-9209

News Archive

Exercise offers significant health benefits for patients with chronic kidney dysfunction

Getting off the couch could lead to a longer life for kidney disease patients, according to a study appearing in an upcoming issue of the JClinical Journal of the American Society Nephrology (CJASN).

Researchers reveal mechanism of early-stage anthrax infection

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.

FDA clears Olive Medical's OVS1 ALL-IN-ONE HD Visualization system

Olive Medical Corporation of Salt Lake City, UT, a growth company, announces 510K clearance and the worldwide sales launch for the OVS1 ALL-IN-ONE HD Visualization system.

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Covagen and Tanabe Research Laboratories U.S.A, Inc., a fully owned subsidiary of Mitsubishi Tanabe Pharma Corporation, today announced that they expanded their strategic research collaboration. MTPC and TRL have nominated a first bispecific FynomAb for formal preclinical development which triggered an undisclosed milestone payment. MTPC and TRL also exercised an option for a second bispecific FynomAb program based on the parties' research and licensing agreement signed in October 2012.

Dr Mark Ndugo Keigi, MD - General Practice in Bear, DE